Streetbeat News

Stock Prices

AAPL

NVDA

PLTR

QQQ

TSLA

The article lists the top 10 trending stocks on WallStreetBets as of September 9, 2024, according to Swaggy Stocks. The stocks mentioned include NVDA, AAPL, TSLA, PLTR, and QQQ among others.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:17 pm

CNTM

RVP

STIM

Insider buying activity was noted in three penny stocks: Neuronetics, ConnectM Technology Solutions, and Retractable Technologies. Despite recent financial challenges, executives are purchasing shares, indicating potential confidence in their companies' futures.

Portfolio Pulse from Avi Kapoor

September 09, 2024 | 1:13 pm

IMVT

TERN

Terns Pharmaceuticals and Immunovant are two health care stocks that may face short-term declines due to being overbought, as indicated by their high RSI values. Both companies have recently reported positive trial results, leading to significant stock gains.

Portfolio Pulse from Avi Kapoor

September 09, 2024 | 1:12 pm

BTCUSD

Julian Bittel, Head of Macro Research at Global Macro Investor, highlights a similarity between Bitcoin's current price structure and its 2019 behavior, suggesting a potential major market move. The coming week is crucial as Bitcoin's price consolidation mirrors 2019's duration, possibly indicating substantial upside momentum.

Portfolio Pulse from Khyathi Dalal

September 09, 2024 | 1:09 pm

ARM

Arm Holdings shares are rising following the announcement that its next-generation AI chip technology will be included in the upcoming iPhone 16.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:08 pm

GMF

TINY

TSM

Taiwan Semiconductor Manufacturing Co (TSM) has achieved production yields at its Arizona plant comparable to its Taiwan facilities, boosting its stock. Despite a recent 9.54% decline, TSM has risen over 75% in the past year. Analysts generally rate it as 'Outperform'.

Portfolio Pulse from Anusuya Lahiri

September 09, 2024 | 1:07 pm

MRK

SMMT

Summit Therapeutics shares rise as their lung cancer candidate outperforms Merck's Keytruda, reducing disease or death risk by 50%.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:06 pm

RZLT

Rezolute shares increased after the FDA lifted partial clinical holds on their drug RZ358.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:02 pm

AMGN

Amgen presented new data at the 2024 World Conference on Lung Cancer, highlighting the potential of IMDELLTRA in combination with PD-L1 inhibitors as a first-line maintenance therapy for extensive-stage small cell lung cancer (ES-SCLC). The DeLLphi-303 study showed promising results, and long-term data from the DeLLphi-301 study demonstrated sustained safety and efficacy.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:02 pm

CL

Analysts have provided mixed evaluations of Colgate-Palmolive (NYSE:CL) over the past three months, with a majority leaning bullish. The average 12-month price target has increased by 5.29% to $106.0. Colgate-Palmolive shows strong financial performance with a high net margin and ROE, but faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 1:00 pm